Surgery Partners Inc. (Nasdaq: SGRY) will remain an independent, publicly traded company following the conclusion of its strategic review process, executives reaffirmed during the company’s second quarter 2025 earnings call. Instead of pursuing a sale to Bain Capital, which had been under consideration prior to June 17, the company will pivot toward selectively selling or partnering assets to accelerate cash flow and reduce debt. “The special committee of independent directors’ decision not to proceed with the proposed acquisition of the company by Bain Capital highlights their belief in the significant value creation opportunity we have in front of us as a publicly traded company,” Surgery Partners CEO Eric Evans said on the call.
Read the full article: Surgery Partners Betting on ASC-Focused Future, ‘Encouraged’ by CMS Proposed Rule //
Source: https://ascnews.com/2025/08/surgery-partners-ditches-bain-deal-bets-on-asc-focused-future/